Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect in Renal Function on Patients With Type 1 Cardiorenal Syndrome Treated With Two Strategies of Furosemide. A Randomized Controled Trial

NCT04393493 is registered in ClinicalTrials.gov with Hospital Civil de Guadalajara as lead sponsor.

NCT NCT04393493
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04393493 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect in Renal Function on Patients With Type 1 Cardiorenal Syndrome Treated With Two Strategies of Furosemide. A Randomized Controled Trial
Lead sponsor
Hospital Civil de Guadalajara
Phase
Phase 2
Overall status
Completed
Start date
July 1, 2017
Completion date
April 1, 2020
Enrollment
80 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cardiorenal syndrome